Targeted pharmaceutical interventions formulated to combat environmental respiratory pathogens in Namibian poultry and livestock farms.
Namibia’s livestock sector forms the backbone of its agricultural economy, contributing significantly to export earnings and rural livelihoods. The country’s unique arid and semi-arid climatic conditions, characterized by severe diurnal temperature fluctuations and intense dry spells, place immense physiological stress on livestock and poultry. These harsh conditions make ruminants (cattle, sheep, goats) and commercial poultry highly susceptible to complex respiratory conditions.
Bovine Respiratory Disease (BRD) complexes, infectious coryza, mycoplasmosis, and pasteurellosis are prominent threats that livestock farmers in regions such as Khomas, Omaheke, and Otjozondjupa face constantly. To preserve herd productivity and protect export margins to lucrative markets like the European Union and South Africa, Namibian veterinary distributors require highly bioavailable, chemically stable, and GMP-compliant respiratory therapeutics. QLU Health addresses this critical gap by delivering high-grade veterinary formulations that survive tough supply chains and deliver rapid curative results.
Leading the next generation of veterinary medicine design with focused innovations in pharmacokinetics and eco-stability.
Our formulations use advanced molecular micronization and dynamic carrier technologies to maximize the absorption rate of active pharmaceutical ingredients (APIs) in the gastrointestinal tracts of animals, reducing recovery times.
Specifically tailored for WHO Zone IVb climatic conditions (hot and dry/humid), our packaging and stabilizer matrices ensure that soluble powders and liquid oral solutions do not degrade or cake under intense heat.
We align our synthesis and recommended veterinary treatment protocols with global guidelines to mitigate Antimicrobial Resistance (AMR), ensuring therapeutic solutions remain viable and safe for meat production.
As a premier pharmaceutical developer and exporter, QLU Health manages three state-of-the-art production bases in Shandong, Zhejiang, and Hebei. Our facilities leverage automation and advanced processing technologies to guarantee consistency across production batches. Our manufacturing plants operate strictly under international GMP rules, backed by ISO, FAMI-QS, KOSHER, and HALAL certifications.
By integrating advanced manufacturing technologies with strict internal quality controls, we ensure that every batch of soluble powder, injection, or oral solution shipped to Namibia complies with international veterinary pharmaceutical standards. Our complete control over raw material procurement and final formulation synthesis protects our supply chains from volatility, offering consistent, year-round pricing security for our Namibian partners.
A history of technological progress, geographic expansion, and high-impact pharmaceutical supply chain building.
Initiated operations focused on developing premium pharmaceutical products, food ingredients, and essential vitamins.
Expanded global marketing reach, distributing active pharmaceutical ingredients (APIs), vitamins, and chemical intermediates to international hubs.
Integrated direct manufacturing and marketing networks for high-demand APIs, vitamins, and custom chemical intermediates.
Fully dedicated to the large-scale development, production, and exporting of customized APIs, veterinary pharmaceuticals, and premium chemical solutions worldwide.
Importing veterinary drugs into Namibia requires adherence to local protocols monitored by the Namibia Medicines Regulatory Council (NMRC) and the Ministry of Agriculture, Water, and Land Reform. QLU Health assists distributors with comprehensive regulatory support.
We provide full documentation, including dossiers, Certificates of Analysis (CoA), Stability Test Reports, and GMP credentials. Our global marketing partners in Mumbai and Dubai streamline shipping and logistics, enabling reliable door-to-port delivery to Walvis Bay.
Advanced injectable and powder formulations designed to manage secondary bacterial infections and protect livestock health.
Premium solutions spanning broad-spectrum antibiotics, gut-respiratory dual-action complexes, and pure APIs.
Understanding local regulatory standards, pharmacological classifications, and import mechanics.
Our products, such as the 50% Doxycycline Hydrochloride and 20% Oxytetracycline Injection, are formulated with stability agents that prevent oxidation, clumping, and degradation at elevated temperatures. Our packaging uses double-layered polymer structures and hermetic seals to protect potency and quality from shipment to local farm storage.
We provide a complete registration dossier for Namibian importers. This documentation includes GMP certificates, Certificates of Analysis (CoA), stability test protocols, detailed product composition, safety data sheets (SDS), and batch manufacturing records (BMR) to support compliance checks by the Namibia Medicines Regulatory Council.
Yes, our factory offers private labeling and customized packaging configurations (e.g., specific weights: 100g, 500g, 1kg foil bags; or specific bottle sizes for liquid formulations). We adapt labeling to comply with localized warning regulations and multilingual preferences in southern Africa.
Once an order is confirmed and NMRC clearances are aligned, manufacturing averages 15 to 21 days depending on packaging customizability. Ocean transit from major Chinese shipping ports to Walvis Bay typically takes 30 to 40 days. Airfreight options are available for urgent requests via Windhoek Hosea Kutako International Airport.
Every production batch undergoes strict quality control protocols at our ISO-accredited facilities. We utilize High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) to verify chemical purity, dissolution rates, and microbiological limits, ensuring compliance with global pharmacopoeias (USP, BP, EP).
QLU Health
